Amae Health Featured on Advancements with Ted Danson

Is schizophrenia genetic? Yes, genetics plays a major role. Research attributes up to about 80% of the risk of developing schizophrenia to genetic factors. But that number comes with an important qualification: no single gene causes schizophrenia, and genes are not the whole story. Having a relative with the condition raises a person's risk, yet most people with an affected relative never develop it, and most people who do develop schizophrenia have no family history of it at all. Genetic risk is real, but it is not destiny. This article explains what the genetics actually show, what else contributes, the types and early signs, and what it means for families.

Is Schizophrenia Hereditary? What the Genetics Show

Schizophrenia can run in the family, and decades of twin, family, and adoption studies have measured how strongly. Twin studies are especially informative. Because identical twins share nearly all their genes while fraternal twins share about half, comparing how often each type of twin shares a diagnosis lets researchers estimate the genetic contribution. Those studies put the heritability of schizophrenia at roughly 79% to 81%, meaning genetic differences account for a large share of why some people develop it and others do not (Sullivan et al., Archives of General Psychiatry, 2003; Hilker et al., Biological Psychiatry, 2018).

‍

It helps to be clear about what heritability does and does not mean. It describes how much of the variation in risk across a population is linked to genetic differences; it does not mean an individual has an 80% chance of developing the condition, and it does not mean the outcome is fixed at birth. Even in identical twins, when one twin has schizophrenia the other develops it only about half the time, which tells us plainly that genes load the dice but do not determine the roll.

‍

So is schizophrenia genetically inherited in a simple way like eye color? No. It is polygenic, which means many genes are involved rather than one. Thousands of common gene variants each add a tiny amount of risk, and a smaller number of rarer variants carry larger effects. Many of these genes influence how brain cells form connections, called synapses, and how chemical messengers between neurons work. There is no single "schizophrenia gene," and because the genetics are spread across so many variants, schizophrenia does not follow a clear-cut pattern of inheritance the way some conditions do (MedlinePlus, Schizophrenia).

How Family History Affects Risk

Family history is the strongest single predictor of risk. The figures below come from classic family and twin studies, and they are best read as approximate lifetime risks for a population, not as a fixed forecast for any one person.

‍

Family history

Approximate lifetime risk

‍

Put another way, having one first-degree relative (a parent or sibling) with schizophrenia raises an individual's risk roughly eight-fold, and having two first-degree relatives raises it about eleven-fold compared with someone with no family history.

‍

A first-degree relative means a parent, sibling, or child (the family members who share about half of your genes). Second-degree relatives, such as grandparents, aunts, and uncles, share less, which is why the risk from a grandparent with schizophrenia is much closer to the general-population figure.

‍

Those numbers can look frightening, so it is essential to read them alongside two facts that are just as true. First, about four out of five people who develop schizophrenia have no affected first-degree relative. Most cases are what researchers call sporadic, arising without a clear family history. Second, even at the highest end of the table, the majority outcome is not developing the condition. With one affected parent, roughly 85 to 90% of children do not develop schizophrenia, and with both parents affected, the majority still do not. Elevated risk is real. Inevitability is not. If you are reading this table with a specific family member in mind, the most useful takeaway is not a percentage but a plan: know the early signs, and know that early care helps.

What Causes Schizophrenia? Beyond Genetics

If you are asking what causes schizophrenia, the honest answer is that genes and environment work together, shaping brain development over time. No single factor acts alone, and there is no one "cause" that applies to everyone. Two people can arrive at the same diagnosis by very different routes, one carrying more genetic risk, another shaped more by environmental factors. This is part of why schizophrenia looks somewhat different from person to person. Alongside genetic risk, researchers have identified several contributors that may increase the likelihood of developing schizophrenia:

‍

• Prenatal and birth factors: complications during pregnancy or birth, maternal infections, or malnutrition before birth.
• Brain chemistry: differences in neurotransmitter systems, particularly dopamine and glutamate, that affect how brain signals are regulated.
• Brain structure and development: subtle differences in brain structure and in how regions connect to one another.
• Substance use: frequent cannabis use in adolescence, especially in people who already carry higher genetic risk.
• Early-life stress or trauma: severe childhood adversity.
• Immune and inflammatory factors: some research links immune activation during key developmental windows to later risk.

‍

Each of these is associated with increased risk rather than a guaranteed cause. Most people exposed to any one of them never develop schizophrenia. The current understanding is what researchers call a neurodevelopmental model: genetic vulnerability and environmental factors interact over years, subtly shaping how the brain develops long before any symptoms appear. This is why schizophrenia typically emerges in late adolescence or early adulthood, a period of major brain maturation, rather than in childhood. It is the combination of influences across development, not any single element, that determines whether the condition emerges. That also means risk is not static: some environmental contributors, like heavy adolescent cannabis use, are ones a person or family can act on.

Types of Schizophrenia

The way clinicians classify schizophrenia has changed. Before 2013, the condition was divided into five subtypes. The DSM-5, and the current DSM-5-TR, folded those subtypes into a single diagnosis of schizophrenia. The reason for the change was that the old subtypes were not stable over time. A person could shift from one to another, and they did not reliably predict treatment response or outcome. In their place, clinicians now use specifiers, notes that describe features like the course of the illness or the presence of catatonia, to capture a person's particular pattern. The older subtype names still appear in some writing, so they are worth knowing:

‍

• Paranoid: prominent delusions and hallucinations.
• Disorganized (hebephrenic): disorganized thinking and speech, and flattened emotional expression.
• Catatonic: movement disturbances, including immobility or mutism.
• Undifferentiated: features of more than one type.
• Residual: reduced symptoms following a previous episode.

‍

Schizophrenia also sits within a broader schizophrenia spectrum that includes related conditions such as schizoaffective disorder, which combines features of schizophrenia and a mood disorder, and schizophreniform disorder, which involves similar symptoms over a shorter period. A clinician distinguishes between these based on the specific pattern and duration of symptoms.

Early Signs of Schizophrenia

The early signs of schizophrenia usually appear in late adolescence or early adulthood, often slightly later in women than in men. Before a first episode, changes can be gradual and easy to miss, which is exactly why families search for them. Common early signs include:

‍

• Social withdrawal and loss of interest in friends or activities
• A decline in functioning at school or work
• Difficulty concentrating or increasingly disorganized thinking
• Unusual or suspicious thoughts, or a sense that something has changed
• Reduced emotional expression or motivation
• Changes in sleep or personal hygiene

‍

Clinicians sometimes call this gradual early phase the prodrome, a period of subtle changes that can precede a first episode by months or even years. These signs are not proof of schizophrenia; many have other explanations, from depression to ordinary adolescent change, and most people who experience them will not develop schizophrenia. But when several appear together and persist, they are a reason to seek an evaluation rather than to wait and see.

‍

A first episode of psychosis, which can include hallucinations, delusions, or disorganized speech, is a particularly important moment. Research consistently shows that the sooner coordinated care begins after psychosis emerges, the better the long-term outcomes tend to be (NIMH, Schizophrenia). Seeking an evaluation early is not an overreaction; it is one of the few things clearly within a family's control that improves the odds.

What This Means for Families

If schizophrenia is in your family, the worry behind the question is usually personal: does this mean it will happen to me, or to my child? The evidence offers a genuinely reassuring answer. A family history raises risk, but it does not make the condition inevitable, and genetic risk is not the same as genetic destiny.

‍

A few things are worth holding onto. There is no routine genetic test that can predict or diagnose schizophrenia, because the condition involves thousands of genes interacting with the environment; diagnosis is clinical, based on symptoms and history. Direct-to-consumer genetic tests that claim to estimate psychiatric risk cannot tell an individual whether they will develop schizophrenia, and a worrying result from one is not a diagnosis.

‍

What families can do is practical rather than passive: learn the early signs, seek an evaluation promptly if concerns come up rather than waiting, and know that effective treatment exists. Modern care combines medication, therapy, and support to help people manage symptoms and build stable, meaningful lives, and outcomes are best when treatment starts early and stays coordinated. For someone carrying a family history, that is the real source of agency: not the genes they inherited, which no one chooses, but the speed and quality of the care they can reach if it is ever needed.

‍

At Amae Health, schizophrenia is one of the conditions our integrated teams are built to treat. If you are looking for information, our guide to the best treatment for schizophrenia and our care for psychosis and first-episode psychosis explain what evidence-based treatment looks like. You can also explore our full range of treatments or read our resources for patients and families. To ask about an evaluation, reach out to our team.

Frequently Asked Questions

Is schizophrenia genetic or environmental?

Both. Genetics accounts for up to about 80% of risk, but environmental factors such as prenatal complications, early trauma, and heavy cannabis use interact with genes to shape whether the condition develops. Neither genes nor environment alone fully explains it.

‍

If a parent has schizophrenia, will their child get it?

Not necessarily. With one parent affected, a child's lifetime risk is roughly 10 to 15%, which means most children of a parent with schizophrenia do not develop it. The risk is higher than average, but it is far from certain.

‍

Can you have schizophrenia with no family history?

Yes. About four out of five people with schizophrenia have no affected first-degree relative. Genetic risk can come from many small variants that are common in the population, and environmental factors also contribute, so the condition frequently appears without a clear family history.

‍

Is there a genetic test for schizophrenia?

No. There is no routine test that can predict or diagnose schizophrenia. Because the condition involves thousands of genes plus environmental influences, no single test can capture it. Diagnosis is made clinically, based on symptoms and history.

‍

At what age does schizophrenia usually appear?

Typically in late adolescence to early adulthood, and often slightly later in women. Early, subtle signs can appear gradually in the months or years before a first episode of psychosis.

‍

Can schizophrenia be prevented if it runs in my family?

It cannot be reliably prevented, but risk can be lowered and outcomes improved. Avoiding heavy cannabis use, managing stress, and seeking evaluation early if warning signs appear all help, and early intervention is linked to better outcomes. If you or a loved one is struggling, support is available: call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

1. Sullivan PF, Kendler KS, Neale MC. "Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies." Archives of General Psychiatry, 2003. PubMed 14662550. Tier 1 (peer-reviewed meta-analysis).
2. Hilker R, Helenius D, Fagerlund B, et al. "Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register." Biological Psychiatry, 2018. sciencedirect.com. Tier 1 (peer-reviewed).
3. MedlinePlus (National Institutes of Health), "Schizophrenia." medlineplus.gov/genetics/condition/schizophrenia. Tier 2 (U.S. government).
4. National Institute of Mental Health, "Schizophrenia." nimh.nih.gov/health/topics/schizophrenia. Tier 2 (U.S. government).

‍

Finding the right mental health clinic in the Bay Area means looking past rankings and into fit: what your condition actually requires, how intensive the care needs to be, and what your insurance covers. The region runs from San Francisco down the Peninsula into Silicon Valley and across to the East Bay, and its options are just as varied: academic medical centers, specialized outpatient programs, nonprofit community clinics, and public safety-net services. This guide organizes the leading mental health clinics in the Bay Area by what they actually do, so you can find the right category before comparing individual providers.

What to Look for in a Mental Health Clinic in the Bay Area

Comparing mental health clinics in the Bay Area gets easier when you hold each one up against the same handful of factors:

–  Conditions treated. Some clinics specialize in severe or complex conditions like schizophrenia and bipolar disorder; others focus on anxiety, depression, or general outpatient therapy. Match the clinic to your diagnosis.

–  Level of care available. Standard outpatient, intensive outpatient (IOP), and partial hospitalization (PHP) are different intensities. Not every clinic offers all three.

–  Team composition. Look at who delivers care: psychiatrists, licensed therapists, peer support, primary care. Integrated teams coordinate these under one roof.

–  Insurance accepted. Verify in-network status before booking, since the same program can cost very differently by plan.

–  Wait times. Some clinics offer same-day or next-day evaluations; academic centers often have longer waitlists.

–  Location. Proximity matters for a program you attend several days a week. Consider San Mateo, Los Altos, Palo Alto, San Jose, or San Francisco.

Best Mental Health Clinics in the Bay Area

Bay Area clinics fall into distinct categories, each built for a different need: integrated care for serious mental illness, academic medical centers, health-system programs, nonprofit community care, specialty outpatient therapy, and public safety-net services. The best clinic is the one whose category fits your situation, so the providers below are organized that way.

Details were verified from each provider as of 2026; confirm current specifics directly, since programs and insurance networks change.

Amae Health: Integrated Care for Adult Severe Mental Illness

Amae Health operates two Peninsula clinics, in San Mateo and Los Altos, providing integrated outpatient care for adults 18 and older living with severe and complex mental illness. We treat schizophrenia, schizoaffective disorder, bipolar disorder, first-episode psychosis, and treatment-resistant depression.

The difference is the team, not any single service. Every patient works with a coordinated group under one roof: psychiatrists, therapists trained in CBT and DBT, group therapy, peer support specialists, health coaches, and primary care. We offer both a Partial Hospitalization Program and an Intensive Outpatient Program, so the level of care can shift as your needs change, without changing teams. Learn more about our Bay Area clinics (San Mateo, Los Altos).

–  Level of care: PHP and IOP

–  Specialties: Schizophrenia, schizoaffective disorder, bipolar disorder, first-episode psychosis, treatment-resistant depression

–  Insurance: Aetna, Anthem Blue Cross, Blue Shield of California, Cigna/Evernorth, and Optum; same-day appointments available

–  Best for: Adults with serious or complex mental illness who want fully integrated, psychiatrist-led care on the Peninsula

Stanford and UCSF: Academic Medical Center Care

Stanford Medicine and UCSF Health anchor the Bay Area’s academic psychiatry. The Stanford Psychiatry Clinic in Palo Alto provides outpatient care for adults across a wide range of conditions, including specialized programs for seniors, women, and patients with co-existing medical conditions. UCSF delivers all-ages outpatient care from its Nancy Friend Pritzker Psychiatry Building in San Francisco. Both offer research-driven subspecialty expertise, though waitlists are typically longer.

–  Level of care: Standard outpatient and specialty clinics

–  Specialties: Subspecialty and research-based care across mood, anxiety, psychotic, and complex conditions

–  Best for: Patients seeking academic-center subspecialty care who can wait for intake

Sutter Health: Health-System Programs for Adults and Adolescents

Sutter Health runs PHP and IOP programs through its Bay Area hospitals, including Mills-Peninsula in San Mateo and Alta Bates Summit in the East Bay. Its programs serve both adults and adolescents, use evidence-based approaches like CBT and DBT alongside art, music, and drama therapies, and connect to inpatient and interventional psychiatry within the same system.

–  Level of care: PHP and IOP

–  Specialties: General psychiatric care for adults and adolescents, with system-wide continuity

–  Insurance: Accepts most major plans, including Medi-Cal

–  Best for: Adults and adolescents who want a large health system with connected levels of care

La Cheim Behavioral Health: Nonprofit Community Care in the East Bay

La Cheim Behavioral Health Services is an Oakland nonprofit that has provided PHP and IOP to the Bay Area since 1993. Its programs deliver intensive group- and milieu-based day treatment for adults in mental health crisis, available on-site or by video, with a longstanding focus on serving marginalized and underserved community members.

–  Level of care: PHP and IOP (in-person or virtual)

–  Specialties: Group-based day treatment for adults in crisis

–  Best for: East Bay adults seeking nonprofit community-based intensive outpatient care

Bay Area CBT Center: Specialty Evidence-Based Therapy

Bay Area CBT Center is a San Francisco group practice specializing in evidence-based talk therapy: CBT, DBT, ACT, Schema Therapy, and EMDR. It focuses on anxiety, depression, OCD, trauma, and ADHD through individual, couples, family, and group therapy. This is a therapy-first practice rather than a PHP or IOP program, well suited to people who need structured outpatient therapy rather than daily psychiatric programming.

–  Level of care: Standard outpatient therapy

–  Specialties: Anxiety, OCD, trauma, depression, and ADHD, using evidence-based modalities

–  Best for: Adults seeking specialized therapy for anxiety, OCD, or trauma

San Mateo County BHRS: Public Safety-Net Care

San Mateo County Behavioral Health and Recovery Services (BHRS) is the public mental health and substance use system for county residents who have Medi-Cal or are uninsured. It provides outpatient, crisis, and substance use services across clinics in Daly City, San Mateo, Redwood City, Half Moon Bay, and East Palo Alto, with a 24/7 Access Call Center at 1-800-686-0101.

–  Level of care: Outpatient and crisis services across the county

–  Specialties: Care for children, adults, and older adults on Medi-Cal or without insurance

–  Best for: San Mateo County residents who need low-cost or public behavioral health care

Types of Mental Health Providers in the Bay Area

Different providers do different things. Knowing the distinction helps you narrow the search before booking.

Psychiatrists

Psychiatrists are medical doctors who diagnose mental health conditions, prescribe and manage medication, and sometimes provide therapy. A psychiatrist in San Mateo or Los Altos typically handles the psychiatric evaluation and ongoing medication management, often as part of an integrated care team rather than in isolation. For severe conditions, psychiatric oversight is the backbone of treatment.

Therapists (LCSW, LMFT, Psychologist)

Therapists provide talk therapy, including CBT, DBT, EMDR, and psychodynamic approaches, but cannot prescribe medication. Many people work with both a therapist and a psychiatrist. Integrated clinics coordinate the two under one team so the therapy and medication plan work in sync.

Psychiatric Nurse Practitioners (PMHNP)

Psychiatric-mental health nurse practitioners can diagnose and prescribe in California. They often work alongside psychiatrists in integrated outpatient and PHP/IOP settings, expanding access to medication management and evaluation.

Conditions Treated at Mental Health Clinics in the Bay Area

Most outpatient clinics treat a range of conditions, but some specialize in severe or complex presentations:

–  Schizophrenia and schizoaffective disorder. Specialized PHP and IOP programs provide the structured psychiatric support these conditions require.

–  Bipolar disorder. Best managed at clinics with coordinated psychiatry and therapy. At Amae’s Los Altos clinic, mental health care for bipolar disorder is delivered by an integrated team rather than split across separate providers.

–  Treatment-resistant depression. Some clinics offer TMS, esketamine, or intensive program structures when standard treatment has not worked.

–  First-episode psychosis. Early intervention through IOP or PHP can reduce long-term impact.

–  Major Depressive Disorder and anxiety disorders, including generalized anxiety, panic, OCD, and social anxiety.

–  PTSD and trauma. Look for clinicians trained in EMDR, Cognitive Processing Therapy, or Prolonged Exposure.

–  Co-occurring conditions. Integrated care teams coordinate mental health and substance use treatment together rather than treating them in separate silos.

Levels of Outpatient Mental Health Care in the Bay Area

Outpatient care ranges from weekly sessions to near-daily structured programs, depending on clinical need.

Standard Outpatient

Usually one session per week with a therapist or psychiatrist. Suited to stable symptoms, maintenance, and ongoing medication management.

Intensive Outpatient Program (IOP)

Three to five days per week, two to four hours per session, combining group therapy, individual therapy, and psychiatric management. IOP fits people who need more structure than weekly outpatient care but can maintain daily life.

Partial Hospitalization Program (PHP)

Up to five days per week, four to five hours per day. SAMHSA defines partial hospitalization as ambulatory care delivered more than three hours per day on more than two days per week, the most intensive outpatient tier (SAMHSA, N-SUMHSS Definitions). PHP is used as a step-down from inpatient care or for acute symptoms that need intensive support. Not every Bay Area clinic offers it.

CBT and DBT run through all of these levels; both are among the best-studied psychotherapies for mood, anxiety, and emotion-regulation conditions (NIMH, Psychotherapies).

How to Find the Right Mental Health Clinic in the Bay Area

A practical sequence:

1.  Identify what you need. Medication management, therapy, or a structured program like IOP or PHP? Your symptom severity and daily functioning point to the level.

2.  Verify insurance in-network status before booking. Confirm the copay too.

3.  Search by location, condition, and insurance. SAMHSA’s FindTreatment.gov locator and the Psychology Today therapist directory both filter on all three.

4.  Ask about first available appointments and current wait times. A shorter path to care matters when symptoms are acute.

5.  Confirm the clinic treats your specific diagnosis. Experience with your condition is not a given; ask directly.

If you want to talk through which level of care fits, contact our team and we can help you think it through.

How Much Does Mental Health Treatment Cost in the Bay Area?

Cost depends heavily on insurance. Under the federal Mental Health Parity and Addiction Equity Act, and California’s own parity protections, health plans that cover mental health must apply financial terms no more restrictive than those for medical and surgical care (CMS, MHPAEA).

With insurance: most commercial plans and Medi-Cal cover outpatient mental health care. In-network copays typically run $0 to $50 per session, though IOP and PHP often require prior authorization.

Without insurance: Bay Area costs tend to run above national averages. Psychiatrist visits are often $300 to $500, and therapy sessions $150 to $350, though these are general ranges rather than quotes.

Public and nonprofit options: San Mateo County BHRS provides services for Medi-Cal-eligible and uninsured residents, and some clinics offer sliding-scale fees. Treat every figure here as a starting point and confirm directly with the clinic and your insurer before you begin.

Getting Started

Finding the right clinic is the first step, and it does not have to be the hardest one. If you or someone you love is managing a serious or complex mental health condition on the Peninsula, Amae Health’s Bay Area clinics offer integrated PHP and IOP care with psychiatry, therapy, peer support, and primary care under one team. Explore our full range of treatments, or contact our intake team to talk about whether Amae is the right fit for your situation.

Frequently Asked Questions

What is the best mental health clinic in the Bay Area?

‍There is no single best clinic; it depends on your condition, the care you need, your location, and your insurance. For complex or severe conditions on the Peninsula, Amae Health is a specialist option offering integrated PHP and IOP. For general therapy, a therapy practice or academic medical center may fit better.

What is the difference between IOP and PHP?

‍PHP is more intensive, up to five days per week for four to five hours per day, typically for acute symptoms or a step-down from inpatient care. IOP meets three to five days per week for shorter sessions and suits people maintaining daily functioning who need more than weekly therapy.

Does insurance cover mental health treatment in the Bay Area?

‍Yes. California law and the federal Mental Health Parity Act require most plans to cover mental health comparably to medical care. IOP and PHP may require prior authorization, so verify in-network status and your copay before scheduling.

What is a partial hospitalization program?

‍A PHP is structured outpatient care that meets most weekdays for several hours a day, providing hospital-level support without an overnight stay. It suits acute symptoms or a step-down from inpatient.

Are there mental health clinics near San Mateo or Los Altos?

‍Yes. Amae Health has clinics at both: 1900 O’Farrell Street, Suite 250 in San Mateo, and 167 S. San Antonio Road, Suite 2 in Los Altos. Both offer PHP, IOP, psychiatry, and therapy.

What conditions do outpatient mental health clinics in the Bay Area treat?

‍Depression, anxiety, bipolar disorder, schizophrenia, schizoaffective disorder, first-episode psychosis, PTSD, OCD, and co-occurring conditions. Specialties vary, so confirm a clinic’s experience with your diagnosis before booking.

How quickly can I get an appointment at a Bay Area mental health clinic?

‍It varies. Some clinics offer same-day or next-day evaluations, including Amae Health, while academic centers may have longer waitlists. If you are in crisis, call or text the 988 Suicide and Crisis Lifeline at 988 anytime.

Citations

1. SAMHSA, National Substance Use and Mental Health Services Survey (N-SUMHSS) Definitions: “Partial hospitalization/day treatment.” info.nsumhss.samhsa.gov/definitions.htm. Tier 2 (U.S. government).

2. National Institute of Mental Health, “Psychotherapies.” nimh.nih.gov/health/topics/psychotherapies. Tier 2 (U.S. government).

3. Centers for Medicare & Medicaid Services, “The Mental Health Parity and Addiction Equity Act (MHPAEA).” cms.gov. Tier 2 (U.S. government).

Comparing Spravato vs ketamine infusion treatment means comparing two versions of the same idea: using ketamine's fast action on the brain's glutamate system to treat depression that standard antidepressants haven't relieved. The best comparison so far, a 2025 meta-analysis by Mayo Clinic researchers, found no statistically significant difference in how often the two lead to response or remission. What separates them is everything around the drug: FDA status, how it's given, how quickly it tends to work, what it costs, and who pays.

‍

So far, neither has been shown to be the better drug.

What Is Spravato (Esketamine)?

Esketamine vs ketamine comes down to chemistry. Standard ketamine is an equal mix of two mirror-image forms of the same molecule. Esketamine is one of those forms on its own, and Spravato is esketamine delivered as a nasal spray.

‍

The FDA first approved Spravato in 2019 for treatment-resistant depression, taken together with an oral antidepressant, as the Mayo Clinic review notes. A second approval, again paired with an oral antidepressant, covers depressive symptoms in adults with major depressive disorder who have acute suicidal thoughts or behavior. And the most recent change came in January 2025, when the FDA added standalone use for treatment-resistant depression, as the current prescribing information shows.

‍

Every dose happens in a certified healthcare setting under the Spravato REMS, an FDA-required safety program. Each device delivers 28 mg, and a session uses two or three devices (56 or 84 mg), with a five-minute wait after each one. You're then monitored for at least two hours, and you can't drive again until the next day, once you've had a restful night's sleep. The label sets the early schedule: twice a week for weeks one through four, once a week for weeks five through eight, then weekly or every two weeks, adjusted to the least frequent dosing that maintains the response.

What Is Ketamine Infusion Therapy?

A ketamine infusion uses standard ketamine, both mirror-image forms together, delivered through an IV line. Ketamine has been FDA-approved as an anesthetic since 1970, but for depression, IV ketamine "remains an off-label treatment," in the Mayo Clinic review's words. Off-label prescribing is legal and common in medicine. It also means there is no FDA-approved depression regimen, so dosing schedules and safety protocols are set by each clinic.

‍

The most studied dose is 0.5 mg per kilogram of body weight, infused over about 40 minutes with continuous heart and blood pressure monitoring. A first course typically runs two to three infusions a week for about three to six treatments, followed by maintenance sessions on a schedule that varies from clinic to clinic.

Spravato vs Ketamine Infusion: Side-by-Side Comparison

Efficacy: What the Research Shows

The most complete head-to-head evidence is the 2025 Mayo Clinic meta-analysis in Therapeutic Advances in Psychopharmacology. The authors identified eight studies with 978 patients in total. Only one was a randomized trial, and it compared IV ketamine with an IV form of esketamine rather than the nasal spray, so the pooled comparison rests on observational studies of IV ketamine versus nasal esketamine.

‍

In those studies, the odds of response were 1.26 times higher with IV ketamine and the odds of remission 1.31 times higher, but neither difference was statistically significant. The authors concluded that the evidence suggests no significant difference in short-term efficacy, with a slight numerical trend favoring IV ketamine.

‍

Speed may be where the two differ. In one Mayo Clinic observational study included in the review, people reached remission after a median of two IV ketamine treatments, compared with seven nasal esketamine treatments. That's a real gap in lived experience. But it comes from observational data, where the people who choose or can access each treatment may differ in ways a study can't fully account for.

‍

So is Spravato better than ketamine infusions? On current evidence, neither has been shown to be. A randomized trial built to settle the question, called EQUIVALENCE, plans to assign 400 people to one treatment or the other for eight sessions over four weeks. Its protocol was published in 2026, and results are not yet available.

FDA Approval and Insurance Coverage

FDA approval changes who pays. Because Spravato has approved indications, insurers can write coverage criteria around it, and they typically require prior authorization and documentation of earlier antidepressant trials. Ketamine infusions for depression are off-label, so coverage is inconsistent, and many people pay out of pocket.

‍

The Spravato vs ketamine cost comparison has a twist. Economic modeling cited in the Mayo Clinic review found nasal esketamine unlikely to be cost-effective compared with IV ketamine from a health-system perspective. Yet an individual patient's out-of-pocket cost for Spravato may be lower, thanks to insurance coverage or manufacturer assistance. Published price estimates vary too widely by dose, frequency, and coverage to quote a single figure, so ask each provider and your insurer for the numbers that apply to you.

Side Effects and Safety Considerations

Because both drugs act on the same receptor, their side effects overlap. In Spravato's clinical trials, 48% to 61% of people developed sedation, and 61% to 84% experienced dissociative or perceptual changes, such as distortions of time or space, according to the prescribing information. Dizziness, nausea, vertigo, anxiety, and a temporary rise in blood pressure are also common, which is why blood pressure is rechecked about 40 minutes after dosing. IV ketamine produces the same family of effects, concentrated during and shortly after the infusion.

‍

Direct safety comparisons are limited. In one retrospective analysis included in the Mayo Clinic review, a rise in blood pressure during treatment occurred in 45% of IV ketamine patients versus 9.2% of nasal esketamine patients, and dissociative effects were also more frequent with IV ketamine, though they were described as transient. That is one retrospective study. It doesn't establish either drug as safer overall.

‍

Both drugs carry a potential for misuse, which shapes who is a candidate, and each has its own exclusions. Spravato, for example, isn't used in people with aneurysmal blood vessel disease, an arteriovenous malformation, or a history of bleeding in the brain.

What Influences the Choice Between Them

There isn't a universal right answer. A psychiatrist weighing the two usually considers:

‍

• Coverage and cost. Whether insurance will cover Spravato in your situation, and whether infusions are affordable out of pocket.
• How quickly relief is needed. Early data suggest infusions may reach remission in fewer sessions, which matters more when symptoms are severe.
• Medical history. Blood pressure, vascular conditions, and any history of substance misuse.
• Route. Some people would rather avoid an IV line. Others prefer an infusion that can be slowed or stopped.
• Logistics. Spravato means at least two hours in the clinic and no driving until the next day, twice a week at first. Infusions take about 40 minutes, plus recovery time that varies by clinic.
• Continuity. Whether you're already established with a psychiatrist or clinic that offers one of them.

‍

The choice belongs in a conversation with a psychiatrist who knows your treatment history, not in a ranking of favorites.

Making the Decision With a Psychiatrist

Spravato and ketamine infusions are tools for treatment-resistant depression, not a complete plan. They work alongside medication, therapy, and ongoing psychiatric care, and they sit among other options, including TMS therapy for depression that hasn't responded to medication. When depression brings thoughts of suicide, care for suicidal thoughts comes first.

‍

We don't offer Spravato at Amae. Our psychiatrists treat depression that hasn't responded to medication through our integrated care model, with therapy, medication management, and TMS, which we provide in Los Altos, San Mateo, and Los Angeles. Whether the question is Spravato vs ketamine infusion or something else entirely, talk through your options with an Amae psychiatrist, including ones we don't provide ourselves. For anyone in crisis right now, 988 is a call or text away.

Frequently Asked Questions

Is Spravato more effective than ketamine infusions?

Not on current evidence. A 2025 meta-analysis found no statistically significant difference in response or remission between IV ketamine and nasal esketamine, only a slight numerical trend favoring IV ketamine. Most of that evidence is observational, and a large randomized head-to-head trial is still underway.

Which works faster, Spravato or ketamine infusions?

IV ketamine may reach remission in fewer sessions. In one observational study, the median was two IV infusions versus seven nasal esketamine treatments. Because that finding comes from observational data rather than a randomized trial, treat it as preliminary.

Is Spravato safer than ketamine infusions?

Neither has been established as safer overall. The two share a similar side-effect profile because they act on the same receptor. One retrospective comparison found more blood pressure spikes and dissociation with IV ketamine, but a single study can't settle the question, and individual risk depends on your medical history.

Why is Spravato covered by insurance but ketamine infusions often aren't?

Spravato has FDA approval for treatment-resistant depression, which gives insurers defined criteria for covering it, usually with prior authorization. IV ketamine for depression is off-label, so coverage is inconsistent and infusions are often self-pay.

Can I switch between Spravato and ketamine infusions?

That's a clinical decision to make with a psychiatrist, based on how you've responded, the side effects you've had, your goals, and your coverage. It isn't something to change on your own.

How many sessions does each treatment typically require?

Spravato starts at twice a week for four weeks, then weekly, then weekly or every two weeks based on response. Ketamine infusions often begin with three to six sessions given two to three times a week, followed by maintenance on a schedule that varies by clinic.

‍

Citations

1. Elmosalamy A, Tarikogullari I, Patarroyo-Rodriguez L, et al. Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12615959/
2. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf
3. Wilkinson ST, Prashad S, Dalthorp R, et al. Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: the EQUIVALENCE trial protocol. Contemporary Clinical Trials. 2026;164:108273. https://pubmed.ncbi.nlm.nih.gov/41780747/
4. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍